CVS Health promoted Dr. Sreekanth Chaguturu to lead its healthcare delivery business a year after the company spent $20 ...

CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for ...

CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...

CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor ...

CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of ...

CVS Health adds four new board members after engagement with activist investor Glenview Capital Management, boosting ...

Larry Robbins, Glenview Capital Management CEO, joins CNBC's 'Squawk on the Street' to discuss his firm's four new seats on ...

CVS Health is the first company to earn a Health Equity Accreditation from URAC. The independent nonprofit accrediting ...

Mike Pykosz is no longer president of healthcare delivery at CVS Health. Pykosz, who co-founded Oak Street Health and was CEO ...

Analyst Elizabeth Anderson CFA of Evercore ISI maintained a Buy rating on CVS Health (CVS – Research Report), retaining the price target of $75.00. Don't Miss our Black Friday Offers: Elizabeth ...

CVS Health has named Sreekanth Chaguturu, MD, president of healthcare delivery. Dr. Chaguturu will succeed Mike Pykosz, who decided to exit the company, according to a Nov. 19 news release. In his new ...